CSL warns of lower profit
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
CSL (CSL) says its net profit is likely to grow less than forecast if a court settlement in the United States is approved.
At 1115 AEDT, shares in CSL were 1.25% higher at $66.195, against a slight benchmark index lift of 0.06%.
Chairman John Shine told the group's annual general meeting that although fiscal 2014 net profit was forecast to grow 10%, settlement of the court case would represent a one-off charge reducing net profit by $US39 million ($41.2 million), reducing profit growth to 7%.
The outlook is subject to a number of other variables, Mr Shine said.
CSL has signed an agreement to settle US antitrust class action litigation filed by American and Puerto Rican hospital groups which has been ongoing since 2009.
The settlement includes a $US64 million payment and is subject to US Federal Court approval.
Call 1300 880 160
Start a chat
Schedule a call
